Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance Document: Q9: Quality Risk Management

Q9: Quality Risk Management. This guidance has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. The ICH Steering Committee has endorsed the final draft and recommended its adoption by the regulatory bodies of the European Union, Japan and USA.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) L’adoption pour l’International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (l’ICH) ligne directrice : Q9 : Gestion des risques liés à la qualité
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2018-10-18 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["conférence internationale sur l'harmonisation", "ICH", "ICH des exigences techniques", "enregistrement des produits pharmaceutiques", "produits pharmaceutiques à usage humain", "lignes directrices de l'ICH", "Q9", "gestion des risques qualité"], "en": ["international-conference on harmonisation", "ICH", "ICH of technical-requirements", "registration of pharmaceuticals", "pharmaceuticals for human-use", "ICH guidance", "Q9", "quality risk management"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source